Pseudomonas aeruginosa is associated with increased lung cytokines and asymmetric dimethylarginine compared with methicillin-resistant staphylococcus aureus

Shock

Volumn 36, Issue 5, 2011, Pages 466-470

  Sousse, Linda E ^a   Jonkam, Collette C ^a   Traber, Daniel L ^a   Hawkins, Hal K ^a   Rehberg, Sebastian W ^a   Traber, Lillian D ^a   Herndon, David N ^b   Enkhbaatar, Perenlei ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

arginine metabolism; cytokine; nitric oxide; Oxidative stress; sepsis

Indexed keywords

ARGINASE; INTERLEUKIN 1; INTERLEUKIN 13; N(G),N(G) DIMETHYLARGININE; NITRATE; NITRITE; OXYGEN;

ACUTE LUNG INJURY; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL OXYGEN TENSION; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; FLUID RESUSCITATION; INHALATION; LUNG FUNCTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOUSE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; SEPSIS; SHAM PROCEDURE; SHEEP; SIGNAL TRANSDUCTION;

ANIMALS; ARGININE; CYTOKINES; FEMALE; INTERLEUKIN-1; INTERLEUKIN-13; LUNG; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICE, INBRED C57BL; PSEUDOMONAS AERUGINOSA; SHEEP;

EID: 80054945994     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3182336b45     Document Type: Article

References (46)

1. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546-1554, 2003. (Pubitemid 36437931)
2. Balk RA: Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations. Crit Care Clin 16:179-192, 2000. (Pubitemid 30193846)
3. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368-1377, 2001.
4. Martin G, Brunkhorst FM, Janes JM, Reinhart K, Sundin DP, Garnett K, Beale R: The international PROGRESS registry of patients with severe sepsis: drotrecogin alfa (activated) use and patient outcomes. Crit Care 13:R103, 2009.
5. Enkhbaatar P, Joncam C, Traber L, Nakano Y, Wang J, Lange M, Connelly R, Kulp G, Saunders F, Huda R, et al.: Novel ovine model of methicillin-resistant Staphylococcus aureusYinduced pneumonia and sepsis. Shock 29:642-649, 2007. (Pubitemid 351544086)
6. Jonkam CC, Bansal K, Traber DL, Hamahata A, Maybauer MO, Maybauer DM, Cox RA, Lange M, Connelly RL, Traber LD, et al.: Pulmonary vascular permeability changes in an ovine model of methicillin-resistant Staphylococcus aureus sepsis. Crit Care 13:R19, 2009.
7. Enkhbaatar P, Murakami K, Traber LD, Cox R, Parkinson JF, Westphal M, Esechie A, Morita N, Maybauer MO, Maybauer DM, et al.: The inhibition of inducible nitric oxide synthase in ovine sepsis model. Shock 25:522-527, 2006.
8. Murakami K, Bjertnaes LJ, Schmalstieg FC, McGuire R, Cox RA, Hawkins HK, Herndon DN, Traber LD, Traber DL: A novel animal model of sepsis after acute lung injury in sheep. Crit Care Med 30:2083-2090, 2002.
9. Vidal Melo MF, Harris RS, Layfield D, Musch G, Venegas JG: Changes in regional ventilation after autologous blood clot pulmonary embolism. Anesthesiology 97:671-681, 2002. (Pubitemid 34977328)
10. Lange M, Hamahata A, Traber DL, Esechie A, Jonkam C, Bansal K, Nakano Y, Traber LD, Enkhbaatar P: A murine model of sepsis following smoke inhalation injury. Biochem Biophys Res Commun 39:1565-1560, 2010.
11. Cox RA, Burke AS, Oliveras G, Enkhbaatar P, Traber LD, Zwischenberger JB, Jeschke MG, Schmalstieg FC, Herndon DN, Traber DL, et al.: Acute bronchial obstruction in sheep: histopathology and gland cytokine expression. Exp Lung Res 31:819-837, 2005. (Pubitemid 43732309)
12. Wells SM, Buford MC, Migliaccio CT, Holian A: Elevated asymmetric dimethylarginine alters lung function and induces collagen deposition in mice. Am J Respir Cell Mol Biol 40:179-188, 2008.
13. Gillett AM, Wallace MJ, Gillespie MT, Hooper SB: Increased expansion of the lung stimulates calmodulin 2 expression in fetal sheep. Am J Physiol Lung Cell Mol Physiol 282:L440YL447, 2002. (Pubitemid 34654646)
14. Enkhbaatar P, Traber DL: Pathophysiology of acute lung injury in combined burn and smoke inhalation injury. Clin Sci (Lond) 107:137-143, 2004. (Pubitemid 39070929)
15. Mathru M, Rooney MW, Dries DJ, Hirsch LJ, Barnes L, Tobin MJ: Urine hydrogen peroxide during adult respiratory distress syndrome in patients with and without sepsis. Chest 105:232-236, 1994. (Pubitemid 24029108)
16. Bernard GE, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, LeGall JR, Morris A, Spragg R: The American-European Consensus Conference on ARDS. Am Rev Respir Dis 149:818-824, 1993.
17. Ware LB, Matthay MA: The acute respiratory distress syndrome. N Engl J Med 342:1334-1349, 2000. (Pubitemid 30408719)
18. Lange M, Nakano Y, Traber DL, Hamahata A, Esechie A, Jonkam C, Bansal K, Traber LD, Enkhbaatar P: Role of different nitric oxide synthase isoforms in a murine model of acute lung injury and sepsis. Biochem Biophys Res Commun 399:286-291, 2010.
19. Munford RS, Pugin J: Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 163:316-321, 2001. (Pubitemid 32158505)
20. Ying S, Meng Q, Barata LT, Robinson DS, Durham SR, Kay AB: Associations between IL-13 and IL-4 (mRNA and protein), vascular cell adhesion molecule-1 expression, and the infiltration of eosinophils, macrophages, and T cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J Immunol 158:5050-5057, 1997. (Pubitemid 127483832)
21. Andrades M, Ritter C, de Oliveira MR, Streck EL, Fonseca Moreira JC, Dal-Pizzol F: Antioxidant treatment reverses organ failure in rat model of sepsis: role of antioxidant enzymes imbalance, neutrophil infiltration, and oxidative stress. J Surg Res 167:307-313, 2009.
22. Liaw WJ, Chen TH, Lai ZZ, Chen SJ, Chen A, Tzao C, Wu JY, Wu CC: Effects of a membrane-permeable radical scavenger, tempol, on intraperitoneal sepsisinduced organ injury in rats. Shock 23:88-96, 2005. (Pubitemid 40083033)
23. Simon F, Fernandez R: Early lipopolysaccharide-induced reactive oxygen species production evokes necrotic cell death in human umbilical vein endothelial cells. J Hypertens 27:1202-1216, 2009.
24. Wang YH, Shen YC, Liao JF, Lee CH, Chou CY, Liou KT, Chou YC: Antiinflammatory effects of dimemorfan on inflammatory cells and LPS-induced endotoxin shock in mice. Br J Pharmacol 154:1327-1338, 2008.
25. Xie K, Yu Y, Zhang Z, Liu W, Pei Y, Xiong L, Hou L, Wang G: Hydrogen gas improves survival rate and organ damage in zymosan-induced generalized inflammation model. Shock 34:495-501, 2010.
26. Dowling RB, Newton R, Robichaud A, Cole PJ, Barnes PJ, Wilson R: Effect of inhibition of nitric oxide synthase on Pseudomonas aeruginosa infection of respiratory mucosa in vitro. Am J Respir Cell Mol Biol 19:950-958, 1998. (Pubitemid 128354294)
27. Ueda S, Kato S, Matsuoka H, Kimoto M, Okuda S, Morimatsu M, Imaizumi T: Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase. Circ Res 92:226-233, 2003. (Pubitemid 36254279)
28. Vallance P, Leone A, Calver A, Collier J, Moncada S: Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol 20(Suppl 12):S60YS62, 1992. (Pubitemid 23014109)
29. Cantoni GL: Biological methylation: selected aspects. Annu Rev Biochem 44:435-451, 1975.
30. Klatt P, Schmidt K, Uray G, Mayer B: Multiple catalytic functions of brain nitric oxide synthase. Biochemical characterization, cofactor-requirement, and the role of N omega-hydroxy-L-arginine as an intermediate. J Biol Chem 268:14781-14787, 1993. (Pubitemid 23206620)
31. Pou S, Pou WS, Bredt DS, Snyder SH, Rosen GM: Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem 267:24173-24176, 1992.
32. Pritchard KA Jr, Groszek L, Smalley DM, Sessa WC, Wu M, Villalon P, Wolin MS, Stemerman MB: Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res 77:510-518, 1995.
33. Vasquez-Vivar J, Kalyanaraman B, Martasek P, Hogg N, Masters BS, Karoui H, Tordo P, Pritchard KA Jr: Superoxide generation by endothelial nitric oxide synthase: the influence of cofactors. Proc Natl Acad Sci USA 95:9220-9225, 1998. (Pubitemid 28506212)
34. Wells SM, Holian A: Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells. Am J Respir Cell Mol Biol 36: 520-528, 2007. (Pubitemid 46676710)
35. Xia Y, Tsai AL, Berka V, Zweier JL: Superoxide generation from endothelial nitric-oxide synthase. A Ca2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem 273:25804-25808, 1998.
36. Bulau P, Zakrzewicz D, Kitowska K, Leiper J, Gunther A, Grimminger F, Eickelberg O: Analysis of methylarginine metabolism in the cardiovascular system identifies the lung as a major source of ADMA. Am J Physiol Lung Cell Mol Physiol 292:L18YL24, 2007. (Pubitemid 46103426)
37. Enkhbaatar P, Connelly R, Wang J, Nakano Y, Lange M, Hamahata A, Horvath E, Szabo C, Jaroch S, Holscher P, et al.: Inhibition of neuronal nitric oxide synthase in ovine model of acute lung injury. Crit Care Med 37:208-214, 2009.
38. Enkhbaatar P, Murakami K, Shimoda K, Mizutani A, McGuire R, Schmalstieg F, Cox R, Hawkins H, Jodoin J, Lee S, et al.: Inhibition of neuronal nitric oxide synthase by 7-nitroindazole attenuates acute lung injury in an ovine model. Am J Physiol Regul Integr Comp Physiol 285:R366YR372, 2003. (Pubitemid 36898906)
39. Enkhbaatar P, Murakami K, Shimoda K, Mizutani A, Traber L, Phillips G, Parkinson J, Salsbury JR, Biondo N, Schmalstieg F, et al.: Inducible nitric oxide synthase dimerization inhibitor prevents cardiovascular and renal morbidity in sheep with combined burn and smoke inhalation injury. Am J Physiol Heart Circ Physiol 285:H2430YH2436, 2003. (Pubitemid 37443059)
40. Enkhbaatar P, Murakami K, Shimoda K, Mizutani A, Traber L, Phillips GB, Parkinson JF, Cox R, Hawkins H, Herndon D, et al.: The inducible nitric oxide synthase inhibitor BBS-2 prevents acute lung injury in sheep after burn and smoke inhalation injury. Am J Respir Crit Care Med 167:1021-1026, 2003. (Pubitemid 36408169)
41. Maybauer DM, Maybauer MO, Szabo C, Westphal M, Traber LD, Enkhbaatar P, Murthy KG, Nakano Y, Salzman AL, Herndon DN, et al.: Lung-protective effects of the metalloporphyrinic peroxynitrite decomposition catalyst WW-85 in interleukin-2 induced toxicity. Biochem Biophys Res Commun 19:786-791, 2008.
42. Lange M, Enkhbaatar P, Nakano Y, Traber DL: Role of nitric oxide in shock: the large animal perspective. Front Biosci 14:1979-1989, 2010.
43. Rudolph V, Freeman BA: Cardiovascular consequences when nitric oxide and lipid signaling converge. Circ Res 105:511-522, 2009.
44. Moncada S, Palmer RM, Higgs EA: The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension 12:365-372, 1988.
45. Murakami K, Enkhbaatar P, Yu YM, Traber LD, Cox RA, Hawkins HK, Tompkins RG, Herndon D, Traber DL: L-Arginine attenuates acute lung injury after smoke inhalation and burn injury in sheep. Shock 28:477-483, 2007. (Pubitemid 47415260)
46. Hesse M, Modolell M, La Flamme AC, Schito M, Fuentes JM, Cheever AW, Pearce EJ, Wynn TA: Differential regulation of nitric oxide synthase-2 and arginase-1 by type 1/type 2 cytokines in vivo: granulomatous pathology is shaped by the pattern of L-arginine metabolism. J Immunol 167:6533-6544, 2001. (Pubitemid 33081589)